A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic
Clinical trial NCT04369365 · COMPLETED
Trial details
- NCT number
- NCT04369365
- Sponsor
- Prof. Dr. Matthias Preusser
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-27
- Primary completion
- 2021-06-15
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.